Perihan Perkin

4PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 03, 2025
Adjuvant nivolumab vs pembrolizumab in stage IIB/IIC melanoma: a reinforcement learning-based simulation study.

Perihan Perkin, Fahriye Tuğba Köş

|Oct 29, 2025
Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features.

Doğan Bayram, Oznur Bal, Efe Cem Erdat

|Apr 25, 2025
A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score.

Doğan Bayram, Öznur Bal, Kemal Karaman

|Feb 20, 2025
Pembrolizumab associated immune thrombocytopenia.

Perihan Perkin, Serhat Sekmek, Dogan Bayram

Pageof 1

Frequent Collaborators

3 joint publications

Serhat Sekmek

3 joint publications

Dogan Bayram

2 joint publications

Fahriye Tugba Kos

2 joint publications

Öznur Bal